Moffitt Cancer Center Teams Up With DiMe to Co-Host New Public-Private Partnership

Article

The partnership is called CancerX and comes in response to the White House Cancer Moonshot.

sdecoret, stock.adobe.com

In response to the White House Cancer Moonshot, the Digital Medicine Society (DiMe) and Moffitt Cancer Center announced they are co-hosting CancerX, a new public-private partnership effort to rapidly accelerate the pace of cancer innovation in the U.S., alongside the Office of the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH). They also announced CancerX's inaugural project, which will focus on using digital innovation to reduce disparities and financial toxicity in cancer care and research.

Announced by the White House Cancer Moonshot, CancerX is a public-private partnership to boost innovation in the fight against cancer co-hosted by the Digital Medicine Society (DiMe) and Moffitt Cancer Center.

CancerX uniquely blends DiMe's expertise in convening cross-disciplinary groups to develop clinical-quality resources on a tech timeline with Moffitt's top research and care experts working side-by-side to revolutionize cancer treatment, extend access to the highest-quality care, and save more lives. The initiative is open to all those working in the field who are committed to working collaboratively and share a vision of unleashing the power of innovation to design and create a future that's free of the burden of cancer. Organizations and individuals who are interested in participating can visit https://cancerx.health/ for more information.

Continue reading this story here.

Recent Videos
Dermasensor
© 2024 MJH Life Sciences

All rights reserved.